ANIX
Anixa Biosciences Inc · Healthcare · Market cap $94.2M
Insiders bought $308K net in the last 90 days ·0 sellers, 4 buyers· latest Form 4 filed Oct 22, 2026
Insider Buying
$482K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Oct 22, 2026
KUMAR AMIT
Anixa Biosciences Inc (ANIX) has 22 SEC Form 4 filings (24 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Oct 22, 2026.
Inside the rolling window, 4 insiders at Anixa Biosciences Inc reported 17 open-market purchases totaling $482K and no open-market sales. The most active filer is Chief Executive Officer KUMAR AMIT with 9 filings. Insiders have net bought $452K over the trailing 6 months. The most recent open-market filing is a purchase of 8,000 shares by Chief Executive Officer KUMAR AMIT, dated Oct 22, 2026, worth $22K.
- Industry:Biotechnology
- CEO:Amit Kumar
- Employees:4
- HQ:San Jose, CA, US
- IPO:1983-10-07
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Purchase | 8,000 | $22K | Oct 22 | — | SEC ↗ | |
Catelani MichaelFirst filing | President, COO, & CFO | Purchase | 5,500 | $16K | Sep 30 | cluster-7.5% | SEC ↗ |
| Chief Executive Officer | Purchase | 7,000 | $19K | Sep 28 | cluster-2.9% | SEC ↗ | |
Baskies Arnold MFirst in 8 months | Director | Purchase | 5,000 | $14K | Sep 28 | cluster-2.9% | SEC ↗ |
| Director | Purchase | 49,036 | $132K | Sep 25 | cluster-2.5% | SEC ↗ | |
| Chief Executive Officer | Purchase | 8,000 | $22K | Sep 14 | cluster-3.2% | SEC ↗ | |
| Director | Purchase | 10,000 | $27K | Sep 14 | cluster-3.2% | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $17K | Aug 3 | -20.5% | SEC ↗ | |
| Chief Executive Officer | Purchase | 8,188 | $28K | Jul 28 | -23.0% | SEC ↗ | |
| Chief Executive Officer | Purchase | 3,000 | $11K | Jul 27 | — | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $17K | Jul 21 | — | SEC ↗ | |
| Director | Purchase | 12,000 | $42K | Jul 20 | — | SEC ↗ | |
| Director | Purchase | 2,797 | $9K | Jul 16 | — | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $15K | Jul 13 | — | SEC ↗ | |
Titterton Lewis H jrFirst in 7 months | Director | Purchase | 2,836 | $7K | Jun 17 | — | SEC ↗ |
KUMAR AMITFirst filing | Chief Executive Officer | Purchase | 21,000 | $53K | Jun 16 | — | SEC ↗ |
Baskies Arnold MFirst filing | Director | Purchase | 10,000 | $30K | Jan 29 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ANIX have?
Anixa Biosciences Inc (ANIX) has 22 SEC Form 4 filings (24 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Oct 22, 2026.
When was the most recent SEC Form 4 filing for ANIX?
The most recent Form 4 filing for ANIX on Tracefour is dated Oct 22, 2026.
Who is the most active insider at ANIX?
The most active SEC Form 4 filer at ANIX in the rolling window is Chief Executive Officer KUMAR AMIT, with 9 filings.
What is the net insider flow at ANIX over the last 6 months?
Over the trailing 180 days, insiders at ANIX have net bought $452K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ANIX in the current window?
Inside the rolling window, insiders at ANIX bought $482K and sold $0 based on SEC Form 4 filings.
Can I get alerts for ANIX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Anixa Biosciences Inc (ANIX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Anixa Biosciences Inc is in the Healthcare sector.